Rasburicase and Tumor Lysis Syndrome: Lower Dosage, Consideration of Indications, and Hyperhydration

被引：17
作者：
Darmon, Michael [1 ]
Guichard, Isabelle [1 ]
Vincent, Francois [2 ]
机构：
[1] St Etienne Teaching Hosp, St Etienne, France
[2] Avicenne Teaching Hosp, Bobigny, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 03期
关键词：
SINGLE-DOSE RASBURICASE; 6; MG; ADULTS; HYPERURICEMIA; PROPHYLAXIS; MANAGEMENT; CANCER;
D O I：
10.1200/JCO.2010.32.6751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E67 / E68
页数：2
相关论文
共 14 条
[1]   Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus [J].
Cairo, Mitchell S. ;
Coiffier, Bertrand ;
Reiter, Alfred ;
Younes, Anas .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) :578-586
[2]   Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach [J].
Campara, M. ;
Shord, S. S. ;
Haaf, C. M. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (02) :207-213
[3]   Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review [J].
Coiffier, Bertrand ;
Altman, Arnold ;
Pui, Ching-Hon ;
Younes, Anas ;
Cairo, Mitchell S. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2767-2778
[4]   Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone-Results of a Multicenter Phase III Study [J].
Cortes, Jorge ;
Moore, Joseph O. ;
Maziarz, Richard T. ;
Wetzler, Meir ;
Craig, Michael ;
Matous, Jeffrey ;
Luger, Selina ;
Dey, Bimalangshu R. ;
Schiller, Gary J. ;
Pham, Dat ;
Abboud, Camille N. ;
Krishnamurthy, Muthuswamy ;
Brown, Archie, Jr. ;
Laadem, Abderrahmane ;
Seiter, Karen .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4207-4213
[5]   Prognostic significance of acute renal injury in acute tumor lysis syndrome [J].
Darmon, Michael ;
Guichard, Isabelle ;
Vincent, Francois ;
Schlemmer, Benoit ;
Azoulay, Elie .
LEUKEMIA & LYMPHOMA, 2010, 51 (02) :221-227
[6]   A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults [J].
Giraldez, Miriam ;
Puto, Katarzyna .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (02) :177-179
[7]   Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase [J].
Hummel, Margit ;
Reiter, Sebastian ;
Adam, Katja ;
Hehlmann, Ruediger ;
Buchheidt, Dieter .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (04) :331-336
[8]   Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy [J].
Hutcherson, DA ;
Gammon, DC ;
Bhatt, MS ;
Faneuf, M .
PHARMACOTHERAPY, 2006, 26 (02) :242-247
[9]   Treatment of impending tumor lysis with single-dose rasburicase [J].
Lee, ACW ;
Li, CH ;
So, KT ;
Chan, R .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) :1614-1617
[10]   A sin le dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy [J].
Liu, CY ;
Sims-McCallum, RP ;
Schiffer, CA .
LEUKEMIA RESEARCH, 2005, 29 (04) :463-465
12